StockData

Myomo vs Utah Medical Products

MYO and UTMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MYO and UTMD compare

Utah Medical Products is the larger company, worth 6.3 times as much as Myomo ($229M against $36.4M).

Utah Medical Products pays a dividend yielding 1.7%; Myomo does not pay one.

Utah Medical Products scores higher on the StockData Score (10 against 7 for Myomo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMYOUTMD
Size and price
Market cap$36.4M$229M
Share price$0.919$72.02
Change, 1 year12.6%30.0%
Change, 5 years−89.2%−40.1%
Beta (5Y)3.010.25
Employees184140
StockData Score
Total score710 (better)
Valuation score23 (better)
Growth score2 (better)0
Performance score11
Health score24 (better)
Dividend score02 (better)
Valuation
P/E–22.0×
P/S0.8× (better)6.4×
P/B6.2×1.9× (better)
EV/EBITDA–13.8×
P/FCF–20.0×
FCF yield−22.9%5.0% (better)
Fair value$1.31$75.66
Margin of safety29.9% (better)4.8%
Growth
Revenue growth (TTM)6.1%–
Revenue growth, 5Y average40.1% (better)−1.8%
EPS growth, 5Y average–3.4%
Profitability
Gross margin68.4% (better)57.9%
Operating margin−27.1%28.4% (better)
Net margin−33.5%–
FCF margin−19.2%31.7% (better)
Return on equity−124%–
Return on invested capital–23.9%
Financial health
Debt / equity0.080.00 (better)
Net debt / EBITDA–−8.51
Current ratio2.3148.62 (better)
Altman Z-score−3.6457.18 (better)
Piotroski F-score3–
Dividends and buybacks
Dividend yield–1.7%
Buyback yield–0.81%
Shareholder yield0.00%2.5% (better)
Ownership
Held by institutions30.8%72.8%
Held by insiders16.3%7.3%
Insider net buying, 12 months$203K (better)$66.8K
Short interest, % of float3.5%5.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.